Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pule

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Haematologica|August 18, 2010
Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptorsVirna Marin, Irene Pizzitola, Valentina Agostoni, et al.
Cancer Research|May 20, 2016
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established TumorsLaurie Menger, Anna Sledzinska, Katharina Bergerhoff, et al.
Blood|August 24, 2006
T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cellsJuan Vera, Barbara Savoldo, Stephane Vigouroux, et al.
Molecular Therapy. Methods & Clinical Development|December 15, 2018
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging CellLeila Mekkaoui, Farhaan Parekh, Ekaterini Kotsopoulou, et al.
Bio-Protocol|September 20, 2021
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 SpikeLeila Mekkaoui, Emma M Bentley, Mathieu Ferrari, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2023
Large-scale manufacturing of base-edited chimeric antigen receptor T cellsRosie Woodruff, Farhaan Parekh, Katarina Lamb, et al.
Cancer Immunology Research|June 23, 2023
Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine ReceptorsMatteo Righi, Isaac Gannon, Matthew Robson, et al.
Cancer Research|April 24, 2015
Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory FormationPedro Veliça, Mathias Zech, Sian Henson, et al.
Cytotherapy|July 6, 2016
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigyUlrike Mock, Lauren Nickolay, Brian Philip, et al.
Blood|July 20, 2007
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesConcetta Quintarelli, Juan F Vera, Barbara Savoldo, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Haematologica|August 18, 2010
Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptorsVirna Marin, Irene Pizzitola, Valentina Agostoni, et al.
Cancer Research|May 20, 2016
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established TumorsLaurie Menger, Anna Sledzinska, Katharina Bergerhoff, et al.
Blood|August 24, 2006
T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cellsJuan Vera, Barbara Savoldo, Stephane Vigouroux, et al.
Molecular Therapy. Methods & Clinical Development|December 15, 2018
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging CellLeila Mekkaoui, Farhaan Parekh, Ekaterini Kotsopoulou, et al.
Bio-Protocol|September 20, 2021
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 SpikeLeila Mekkaoui, Emma M Bentley, Mathieu Ferrari, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2023
Large-scale manufacturing of base-edited chimeric antigen receptor T cellsRosie Woodruff, Farhaan Parekh, Katarina Lamb, et al.
Cancer Immunology Research|June 23, 2023
Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine ReceptorsMatteo Righi, Isaac Gannon, Matthew Robson, et al.
Cancer Research|April 24, 2015
Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory FormationPedro Veliça, Mathias Zech, Sian Henson, et al.
Cytotherapy|July 6, 2016
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigyUlrike Mock, Lauren Nickolay, Brian Philip, et al.
Blood|July 20, 2007
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesConcetta Quintarelli, Juan F Vera, Barbara Savoldo, et al.
Pageof 8